Die Blockade der RANK-RANKL Interaktion durch Denosumab bei der Immunüberwachung der Akuten Myeloischen Leukämie durch Natürliche Killerzellen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Tübingen, Universität Tübingen, Dissertation, 2016
- Keyword
-
Immunsystem
Natürliche Killerzelle
Zelle
Hämatologie ; Blutkrankheit ; Immuntherapie ; Immunsystem
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2017
- Creator
- Contributor
-
Salih, H. R.
- URN
-
urn:nbn:de:bsz:21-dspace-781369
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Malinovska, Alexandra
- Salih, H. R.
- Universitätsbibliothek Tübingen
Time of origin
- 2017
Other Objects (12)
Denosumab : RANKL-Inhibition zur Therapie metabolischer und maligner Osteopathien
Expression von RANK / RANKL im Harnblasenkarzinom
RANK/RANKL/OPG system in the intervertebral disc
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
RANKL-RANK signaling regulates osteoblast differentiation and bone formation
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
Translationale Therapie bei Patienten mit Osteogenesis Imperfecta - eine Pilotstudie über die Therapie mit dem RANKL-Antikörper Denosumab
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer
RANK, RANKL and OPG Expression in Breast Cancer – Influence on Osseous Metastasis
Denosumab : RANKL-Inhibition zur Therapie metabolischer und maligner Osteopathien
Expression von RANK / RANKL im Harnblasenkarzinom
RANK/RANKL/OPG system in the intervertebral disc
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
RANKL-RANK signaling regulates osteoblast differentiation and bone formation
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
Translationale Therapie bei Patienten mit Osteogenesis Imperfecta - eine Pilotstudie über die Therapie mit dem RANKL-Antikörper Denosumab
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer
RANK, RANKL and OPG Expression in Breast Cancer – Influence on Osseous Metastasis
Denosumab : RANKL-Inhibition zur Therapie metabolischer und maligner Osteopathien
Expression von RANK / RANKL im Harnblasenkarzinom
RANK/RANKL/OPG system in the intervertebral disc
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
RANKL-RANK signaling regulates osteoblast differentiation and bone formation
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
Translationale Therapie bei Patienten mit Osteogenesis Imperfecta - eine Pilotstudie über die Therapie mit dem RANKL-Antikörper Denosumab
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer